| Literature DB >> 29728878 |
Qishu Jiao1, Rufeng Wang1, Yanyan Jiang1, Bin Liu2.
Abstract
Traditional Chinese medicine (TCM), as a unique form of natural medicine, has been used in Chinese traditional therapeutic systems over two thousand years. Active components in Chinese herbal medicine are the material basis for the prevention and treatment of diseases. Research on drug-protein binding is one of the important contents in the study of early stage clinical pharmacokinetics of drugs. Plasma protein binding study has far-reaching influence on the pharmacokinetics and pharmacodynamics of drugs and helps to understand the basic rule of drug effects. It is important to study the binding characteristics of the active components in Chinese herbal medicine with plasma proteins for the medical science and modernization of TCM. This review summarizes the common analytical methods which are used to study the active herbal components-protein binding and gives the examples to illustrate their application. Rules and influence factors of the binding between different types of active herbal components and plasma proteins are summarized in the end. Finally, a suggestion on choosing the suitable technique for different types of active herbal components is provided, and the prospect of the drug-protein binding used in the area of TCM research is also discussed.Entities:
Keywords: Active components; Plasma protein binding; Research methods; Traditional Chinese medicine
Year: 2018 PMID: 29728878 PMCID: PMC5935606 DOI: 10.1186/s13065-018-0417-2
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
The relationship between thermodynamic parameters and binding forces
| Thermodynamic parameter | Binding force |
|---|---|
| ∆ | May be hydrophobic and electrostatic interactions |
| ∆ | May be hydrogen bonds and van der Waals forces |
| ∆ | Hydrophobic interactions |
| ∆ | Hydrogen bonds and van der Waals forces |
| ∆ | Electrostatic interactions |
Binding parameters for the interaction between active components in TCMs and plasma proteins
| Type | Compounds | Protein | Stoichiometry | Quenching mechanism | Binding site |
| Driving force | References | |
|---|---|---|---|---|---|---|---|---|---|
| Flavone | BSA | 2.139 × 104 | 2.26 | IIA | a, b | [ | |||
| Rutin | HSA | 3.8 × 104 | 1.43 | Static | IIA | a, b | [ | ||
| Quercitrin | BSA | 4.13 × 103 | 2.32 | IIA | b, c | [ | |||
| Kaempferol | HSA | 2.89 × 105 | 0.65 | Static | IIA | 2.7 | c | [ | |
| (+)-catechin | BSA | 1.565 × 104 | 2.17 | Static | IIA | a, b | [ | ||
| Loureirin A | HSA | 1.291 × 105 | 0.88 | Static | IIA | 2.66 | c, d | [ | |
| Cochinchinenin C | HSA | 2.532 × 105 | 0.78 | Static | IIA | 2.975 | c, d | [ | |
| Hesperitin | HSA | 1.29 × 105 | 1.03 | Static | IIA | 1.978 | a, c | [ | |
| Diosmetin | HSA | 1.18 × 105 | 0.84 | Static | IIA | 3.54 | a, c | [ | |
| Apigenin | BSA | 6.978 × 106 | 1.266 | Static | IIA | 1.89 | a, c | [ | |
| HSA | 9.83 × 104 | 0.8774 | Static | IIA | 3.21 | a, b | [ | ||
| Farrerol | HSA | 4.76 × 105 | 0.46 | Static | IIA | 2.63 | a, c | [ | |
| Baicalein | HSA | 1.73 × 105 | Static | IIA | 2.04 | a, c | [ | ||
| Flavonoids | Delphinidin-3- | BSA | 1.98 × 105 | 1.100 | Static | IIA | 2.81 | c, d | [ |
| HSA | 1.443 × 105 | 1.082 | IIA | 2.34 | a | [ | |||
| Pelargonidin-3- | HSA | 6.89 × 104 | 0.995 | Static, dynamic | IIA | 2.83 | c, d | [ | |
| BSA | 1.21 × 105 | 1.057 | Static | IIA | 2.74 | b | [ | ||
| Cyanidin-3- | HSA | 1.096 × 105 | 1.042 | Static, dynamic | IIA | 2.58 | b | [ | |
| Neohesperidin dihydrochalcone | HSA | 2.79 × 104 | 1.02 | Static | IIA | c, d | [ | ||
| Icariin | HSA | 3.0335 × 104 | 1.0282 | Static | IIA | 2.5 | c, d | [ | |
| Guaijaverin | HSA | 2.02 × 105 | 1.121 | Static | IIA | 2.527 | a, b, c | [ | |
| Mangiferin | BSA | 3.18 × 104 | 1.16 | Static | IIA | a, c | [ | ||
| Berberine | BSA | 7.75 × 104 | 0.92 | Static | IIA | b, c, d | [ | ||
| Palmatine | BSA | 7.11 × 104 | 1.17 | Static | IIA | b, c, d | [ | ||
| Paclitaxel | HSA | 3.241 × 102 | 0.93 | Static | IIA | 2.23 | a | [ | |
| Alkaloids | Tetrandrine | BSA | 1.06 × 106 | 1.17 | Static, dynamic | IIA | 1.455 | a, b | [ |
| HSA | 1.59 × 106 | 1.21 | Static, dynamic | IIA | 1.451 | a | [ | ||
| Brucine | BSA | 3.47 × 105 | 1.04 | Static | IIA | 5.08 | a, b | [ | |
| Triterpenes | Glycyrrhetinic acid | HSA | K1 = 1.65 × 105 | N1 = 0.43 | Static | IIA | 1. c | [ | |
| Trans-feruloyl maslinic acid | HSA | 1.42 × 108 | 0.6 | IB | [ | ||||
| Phenyl-propanolds | Ferulic acid | HSA | 7.87 × 103 | Static | IIIA | c | [ | ||
| Caffeic acid | BSA | 4.264 × 105 | 1.173 | Static | 1.86 | c | [ | ||
| Chlorogenic acid | HSA | 3.004 × 104 | 1.14 | Static | Site I | 3.10 | b | [ | |
| Paeonol | HSA | 4.84 × 103 | IIIA | c, d | [ | ||||
| Curcumin | HSA | 1.80 × 105 | 1.14 | Static | IIA | c, d | [ | ||
| Other phenolic substances | Salicylic acid | BSA | 5.60 × 103 | 1.85 | c, d | [ | |||
| N-trans-p-coumaroyltyramine | HSA | 4.5 × 105 | 1.538 | IIA | a | [ | |||
| Syringin | HSA | 2.97 × 104 | 1.336 | Static, dynamic | IIA | 3.15 | a | [ |
K is equilibrium binding constant. Stoichiometry (N) is the number of binding sites considered for the fit. r is the distance between the Trp residue of HSA and the acceptor molecule. Driving force is noncovalent interactions between drugs and biological macromolecules, and a is hydrophobic interaction, b is electrostatic interaction, c is hydrogen bonds and d is van der Walls force